Skip to main content
Caplight Logo









OcuTerra Therapeutics

OcuTerra Therapeutics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://ocuterra.com

Company Overview

OcuTerra Therapeutics is a biotechnology company that developed non-invasive eye drop treatments for diabetic eye diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

diabetic retinopathyophthalmologybiotechnologyeye drop treatmentclinical trialintegrin inhibitordrug developmentnon-proliferative diabetic retinopathyNPDRproliferative diabetic retinopathyPDRsmall-molecule drugeye carebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OcuTerra Therapeutics Comparables

Compare OcuTerra Therapeutics with similar companies based on industry and business-model similarity.

OcuTerra Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exonate
85%
Panoptica
84%
Retinset, S.L.
82%

OcuTerra Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

OcuTerra Therapeutics Filings

Explore SEC and related filing metadata, where available.

OcuTerra Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OcuTerra Therapeutics's valuation, stock price, and market status.

Is OcuTerra Therapeutics a public or private company?

OcuTerra Therapeutics is a private company.

What is the current stock price of OcuTerra Therapeutics?

OcuTerra Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is OcuTerra Therapeutics worth (valuation)?

Valuation information for OcuTerra Therapeutics is not publicly available.

Can I buy OcuTerra Therapeutics stock?

OcuTerra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OcuTerra Therapeutics's last funding round?

Funding round information for OcuTerra Therapeutics is not publicly available.

Who are the main investors in OcuTerra Therapeutics?

Investor information for OcuTerra Therapeutics is not publicly disclosed.

Will OcuTerra Therapeutics IPO soon?

No public IPO plans have been announced for OcuTerra Therapeutics.

How can I track OcuTerra Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OcuTerra Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?